OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for February, 2014

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2014-02-26 12:15 FDA Approves New Catheter For Treatment Of Atrial Fibrillation and more... 2014-02-26 00:15 Merck Abandons Once-Promising Experimental Cancer Drug to Ariad and more... 2014-02-25 12:15 No Looking Back for Regeneron's Eylea and more... 2014-02-25 00:15 VIVUS' Q4 Loss Shrinks 70% as Licensing Revenue Soars and more... 2014-02-24 12:15 3 Under-the-Radar Biotech Stocks You Need to Watch in 2014 and more... 2014-02-23 12:15 Is Buffett Abandoning Health-Care Stocks? and more... 2014-02-23 00:15 China pharmaceutical industry sees steady growth and more... 2014-02-22 12:15 Dividend Derby: Pfizer Vs. Merck and more... 2014-02-22 00:15 2 FDA Decisions You Need to Watch Next Week and more... 2014-02-21 12:15 FDA Program to Loosen Import Restrictions for 13 Major Pharmaceutical Manufacturers and more... 2014-02-21 00:15 Onconova hammered after top drug rigosertib flunks key PhIII study and more... 2014-02-20 12:15 Sunshine Act data is now due, but some provisions remain murky and more... 2014-02-20 00:15 Novo Nordisk targets Mexico for early obesity drug launch and more... 2014-02-19 12:15 Actavis-Forest Bid Shines Light on Valeant Next: Real M&A and more... 2014-02-19 00:15 Chelsea Therapeutics Wins FDA Approval For Northera and more... 2014-02-18 12:15 Billionaire Teva Chairman May Retire by Year?â?ó?éÔé¼?éÔäós End and more... 2014-02-18 00:15 Big Pharma Continues the Race for Electroporation and more... 2014-02-17 12:15 Rumor mill: Apple's working on device to predict heart attacks and more... 2014-02-16 12:15 Soros Makes Drugmaker Teva Biggest Stake as Shares Climb and more... 2014-02-15 12:15 Merck's Decision To Sell Consumer Division Is Timely And Will Lead To A Higher Stock Price and more... 2014-02-15 00:15 Drug Quality Concerns Spur New U.S. FDA Oversight Effort and more... 2014-02-14 12:15 AbbVie Deserves More Respect and more... 2014-02-14 00:15 Medicines Co. shares plummet after FDA follows through with rejection 2014-02-13 12:15 Hackers break into networks of 3 big medical device makers and more... 2014-02-13 00:15 FDA Advisory Panel Recommends Against Approval Of New Medicines Company Heart Drug and more... 2014-02-12 12:15 Galena Biopharma Pays For Stock-Touting Campaign While Insiders Cash Out Millions and more... 2014-02-12 00:15 GlaxoSmithKline R&D chief touts the future of 'electroceuticals' and more... 2014-02-11 12:15 Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders and more... 2014-02-11 00:15 New Drug Shortages Decline in U.S. on Greater Scrutiny and more... 2014-02-10 12:15 Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diab... and more... 2014-02-10 00:15 Merck Falling Earnings Hide Hidden Potential 2014-02-09 00:15 Teva Reports Strong Q4 And 2013 Results and more... 2014-02-08 12:15 Will These Two Drugs Turn Around Losses at Pfizer? and more... 2014-02-08 00:15 The Contrasting Fortunes Of AstraZeneca plc And GlaxoSmithKline plc and more... 2014-02-07 12:15 AbbVie is hit with 5 lawsuits citing the dangers of its 'low T' drug and more... 2014-02-07 00:15 Merck Said to Agree to $100 Million NuvaRing Settlement and more... 2014-02-06 12:15 Circassia Plans $285 Million IPO to Fund Allergy Vaccines and more... 2014-02-06 00:15 AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough? and more... 2014-02-05 12:15 What to Watch at Amgen, Merck, Pfizer, and Myriad Genetics This Morning and more... 2014-02-05 00:15 Eager biotechs crowd into Wall Street this week with $500M in IPO pitches and more... 2014-02-04 12:15 Pfizer approved for Prevenar 13 USPI to include expanded use and more... 2014-02-04 00:15 Why Did One Of The World's Largest Generic Drug Makers Exit China? and more... 2014-02-03 12:15 Smith & Nephew to Buy ArthroCare for $1.7 Billion in Cash and more... 2014-02-03 00:15 FDI in pharma (in India) jumps to $1.25 billion during April -November period and more... 2014-02-02 12:15 The Case For Questcor and more... 2014-02-02 00:15 A Unique Take On Pharmaceutical Research and more... 2014-02-01 12:15 CytRx Flushed Its Shareholders, Even If It Needed the Capital and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe